Shopping Cart
- Remove All
- Your shopping cart is currently empty
FAPI-46 is a quinoline-derived radiotracer that specifically targets fibroblast activation protein (FAP). It exhibits enhanced tumor uptake and extended accumulation in tumor tissues, rendering it suitable for diverse cancer imaging applications.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $747 | Backorder | |
10 mg | $1,360 | Backorder |
Description | FAPI-46 is a quinoline-derived radiotracer that specifically targets fibroblast activation protein (FAP). It exhibits enhanced tumor uptake and extended accumulation in tumor tissues, rendering it suitable for diverse cancer imaging applications. |
In vitro | FAPI-46 (1-24 h) exhibits robust binding to human FAP in human FAP-expressing HT-1080 cells[1]. |
In vivo | FAPI-46, when administered intravenously (i.v.), demonstrates enhanced tumor-to-liver, kidney, and brain uptake ratios, improving image contrast in PET imaging[1]. |
Molecular Weight | 885.972 |
Formula | C41H57F2N11O9 |
Cas No. | 2374782-04-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.